Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes ...

A new human monoclonal antibody moves a step closer to a universal antibody cocktail that works against all strains of SARS-CoV-2. SARS-CoV-2, the virus that causes COVID-19 disease, continues to ...

How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes ...

The FDA on Friday revoked the emergency use authorizations (EUAs) of four monoclonal antibodies for COVID-19. The four drugs -- bebtelovimab, sotrovimab, casirivimab ...

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as distantly related SARS-like coronaviruses that infect other ...

Though the peak of COVID-19 deaths is thankfully behind us, the virus is still a pernicious public health threat that vexes drugmakers by constantly evolving new variants that can elude existing ...

A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important ...